STEP 1 extension trial (Wilding et al., NEJM 2022)
Adding 2 mL of bacteriostatic water to a 5 mg vial gives you 2.5 mg/mL, the most commonly used concentration
Whats New: ASCO GI 2026 Data on GLP-1 Agents At ASCO GI 2026, several large-scale analyses presented the strongest clinical signals to date linking GLP-1 receptor agonist use with reduced colorectal neoplasia risk
However, as per the BEYOND VIII trial, a higher insulin starting dose of 0.3 U/kg/day was equivalent, in terms of safety, to the standard starting dose of 0.2 U/kg/day among overweight/obese people with T2DM, and self-monitored FBG goals were attained earlier with the higher dose vs
GLP-1s have quickly become one of the most popular types of weight-loss drugs in America
For Immunotec, California represents tremendous potential for the continued growth and evolution of the global MLM industry